NCT00034580已完成4 期
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 326
- 试验地点
- 21
研究概览
简要总结
This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female subject, 18-70 years of age
- •Female subjects of childbearing potential must be using a medically accepted means of contraception
- •Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol
- •Subjects must be considered reliable
- •Female subjects who are either pregnant or nursing
- •Uncorrected hypothyroidism or hyperthyroidism
- •Narrow-angle glaucoma
- •Subjects who present a serious and immediate risk of endangering him or herself
排除标准
- 未提供
研究者
研究点 (21)
Loading locations...
相似试验
已完成
4 期
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaSchizophreniaSchizoaffective DisorderDepressionNCT00034801Eli Lilly and Company378
已完成
4 期
Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaSchizophreniaNCT00036088Eli Lilly and Company530
已完成
1 期
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.PharmacokineticsNCT05123976Joint Stock Company "Farmak"32
已完成
4 期
Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaSchizophreniaNCT00103571Eli Lilly and Company600
已完成
4 期
Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaSchizophreniaNCT00088049Eli Lilly and Company560